| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal: TA1045: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites |
|
Medicine details |
|
| Medicine name | 12 SQ-HDM (Acarizax®) |
| Formulation | Sublingual lyophilisate |
| Reference number | 6283 |
| Indication | For treating allergic rhinitis and allergic asthma caused by house dust mites |
| Company | ALK-Abello Ltd |
| BNF chapter | Respiratory system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 31/01/2025 |
| NICE guidance | TA1045: 12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites |